Phase Ib/II trial of copanlisib in combination with trastuzumab and pertuzumab after induction treatment of HER2 positive metastatic breast cancer with PIK3CA mutation or PTEN mutation Meeting Abstract
| Authors: | Damodaran, S.; Murthy, R. K.; Nusrat, M.; Saigal, B.; Trager, S. C.; Tripathy, D.; Meric-Bernstam, F. |
| Abstract Title: | Phase Ib/II trial of copanlisib in combination with trastuzumab and pertuzumab after induction treatment of HER2 positive metastatic breast cancer with PIK3CA mutation or PTEN mutation |
| Meeting Title: | 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-02-01 |
| Language: | English |
| ACCESSION: | WOS:000618737700107 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS20-OT-34-01 |
| Notes: | Meeting Abstract: OT-34-01 -- This symposium was held virtually due to COVID-19 -- Source: Wos |
